21 June 2024 - Version 4 of the agenda for the July 2024 PBAC meeting is now available; four minor changes.

The minor changes are:

• Morphine sulphate (Anamorph) - new formulation
• Ravulizumab (Ultomiris) - new medicine
• Avelumab (Bavencio) - revised sponsorship details
• Review of nurse practitioner items

Read PBAC agenda